Graphite. Source: Adobe Images
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

South Australia focused developer iTech Minerals Ltd (ASX:ITM) has exceeded expectations for metallurgical recoveries from its Lacroma Graphite project, producing a 94 percent TGC (total graphite carbon) concentrate, as well as recoveries of around 95% through an industry standard flotation circuit.

In addition, metallurgical work shows the potential for purified spherical graphite (PSG) to be produced, based on the achievement of high purity fine flake graphite from bench scale metallurgical testing work.

The recoveries have the potential to improve even further through optimisation work using the same graphite flotation process, which is both non-chemical and non-thermal.

Managing director Mike Schwartz said he was thrilled with these results, which had confounded iTech’s expectations.

“We targeted an industry-standard 80 percent recovery rate with our first round of metallurgical test work, so exceeding it by such a significant margin so early on in the process using simple flotation techniques is incredibly encouraging,” he said.

“It really highlights the potential the Lacroma Graphite Project has to produce a high quality, low-cost graphite product for the growing battery materials market.”

The properties of graphite from Lacroma – which is part of iTech’s larger Campoona Graphite Project in South Australia – suggest that a low-cost operation is achievable.

The company is now planning to move on to bulk sampling production, as well as purification and spheroidization test work.

iTech has been trading at 7.8 cents.


ITM by the numbers
More From The Market Online
Red house in Sweden

Talga reaches another goal for Vittangi anode project, with offtake agreement

Talga Group Ltd has signed an offtake agreement for supply of its Talnode -C anode to…
Rejection concept

Insignia takes a -14% hit as Bain Capital walks away from buyout; CC still keen

Insignia Financial (ASX:IFL) has revealed Bain Capital's decided the world is too uncertain right now to…
The Market Online Video

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals

With biotech stocks broadly having a strong run in 2025, and with more of the year…
Niobium on a black background

Encounter posts maiden MRE for Aileron, highlights significance of niobium resource

Encounter Resources Ltd has published an initial mineral resource estimate for its Aileron niobium project in…